Pancreatic Cancer Research

ResearcherSeoul National UniversityActive in the last 2 years

Sang Kook Lee

Matched on ORCID iD 0000-0002-4306-7024; OpenAlex author ID A5033086793, A5159726396. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
18
Papers, trials and grants by year

2022: 1 paper · 2023: 2 papers · 2024: 2 papers · 2025: 1 paper · 2026: 1 paper

Papers 7

  1. Metabologenomic Hallmark-Based Discovery of Bacterial Thioamides as a New Lead against Drug-Resistant Pancreatic Cancer. Co-author DOI 10.1002/advs.202517849↗
  2. Targeting HASPIN in gemcitabine-resistant pancreatic cancer cells by lead optimization of thioadenosine analogue. Co-author DOI 10.1016/j.biopha.2025.118135↗
  3. Evo312: An Evodiamine Analog and Novel PKCβI Inhibitor with Potent Antitumor Activity in Gemcitabine-Resistant Pancreatic Cancer. Last author DOI 10.1021/acs.jmedchem.4c00213↗
  4. Antiproliferative Activity of Piceamycin by Regulating Alpha-Actinin-4 in Gemcitabine-Resistant Pancreatic Cancer Cells. Last author DOI 10.4062/biomolther.2023.109↗
  5. Periplocin exerts antitumor activity by regulating Nrf2-mediated signaling pathway in gemcitabine-resistant pancreatic cancer cells. Last author DOI 10.1016/j.biopha.2022.114039↗
  6. Antiproliferative Activity of Krukovine by Regulating Transmembrane Protein 139 (TMEM139) in Oxaliplatin-Resistant Pancreatic Cancer Cells. Co-author DOI 10.3390/cancers15092642↗
  7. Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsies. Co-author DOI 10.5009/gnl210166↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eun Seo Bae · 4 shared papers, 2023–2026 · strength 0.92
  2. J.H. Lee · 3 shared papers, 2022–2024 · strength 0.48
  3. Ja‐Lok Ku · 3 shared papers, 2022–2024 · strength 0.48
  4. Sang Hyub Lee · 3 shared papers, 2022–2024 · strength 0.48
  5. Ji Kon Ryu · 3 shared papers, 2022–2024 · strength 0.48
  6. Yong‐Tae Kim · 3 shared papers, 2022–2024 · strength 0.48
  7. Dong‐Chan Oh · 2 shared papers, 2024–2026 · strength 0.42
  8. Jin Ho Choi MD · 2 shared papers, 2023–2024 · strength 0.34
  9. Min Woo Lee · 2 shared papers, 2023–2024 · strength 0.34
  10. Woo Hyun Paik · 2 shared papers, 2022–2024 · strength 0.33
  11. Young Eun Du · 1 shared paper, 2026 · strength 0.23
  12. Hyuk‐Jin Cha · 1 shared paper, 2025 · strength 0.23
  13. Yoon-Ze Shin · 1 shared paper, 2025 · strength 0.23
  14. In Rae Cho · 1 shared paper, 2024 · strength 0.18
  15. Haeryoung Kim · 1 shared paper, 2022 · strength 0.14
  16. Soon‐Chan Kim · 1 shared paper, 2022 · strength 0.14
  17. Jung Won Chun · 1 shared paper, 2022 · strength 0.14
  18. Andrew M. Lowy · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.